Helios combines the thermogenic properties of Clenbuterol and Yohimbine into a targeted local area fat loss product. By injecting Helios into the subcutaneous lipid (fat) area, the bioavailability of both blends is transmitted at 100% into the problem area, essentially melting the fat away. Dosages range from 0.1ml to 2ml for each injection site, 6 hours apart each day. Alternating site injection areas every 6 hours allows for an even distribution of Helios, thereby producing an even fat loss pattern.
Mechanism of action of Yohimbine
Yohimbe, and its subset yohimbine, are fat-burning compounds, primarily used to lose fat during short term fasting. Yohimbine is also an aphrodisiac and can aid erectile dysfunction.
Mechanism of action of Clenbuterol
Clenbuterol is a β2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug. It causes an increase in aerobic capacity, central nervous system stimulation, and an increase in blood pressure and oxygen transportation. It increases the rate at which body fat is metabolized while increasing the body's BMR. It is commonly used for smooth muscle relaxant properties. This means that it is a bronchodilator and tocolytic with pronounced fat loss properties.
Packaging: Single vial with silicone stopper, containing 10ml of product.
EACH ML CONTAINS: | ||
Clenbuterol | BP | 40mcg |
Yohimbine | BP | 5mg |
Benzyl Alchohol | BP | 2% |
Dosage & administration:
Half life
36 hours (Clenbuterol) 2.5 hours (Yohimbine)
Adult dose (Male)
0.25ml to 2ml split into multiple injections for subcutaneous injection into higher body fat, problem areas
Adult dose (Female)
0.10ml to 1ml split into multiple injections for subcutaneous injection into higher body fat, problem areas
Average Cycle Length
Follow either a 5 day on 2 day off protocol for higher dosing regimes or 6-8weeks cycles for low dose regimes.
Anabolic #
n/a
Androgenic #
n/a
Bioavailability
100%
CAS Name
17-hydroxy-yohimban-16-carboxylic acid methyl ester
CAS Name
RS-1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol